Abstract
The article deals with nanopharmacy, a new medical discipline that combines chemistry, physics and engineering to develop nanoscale systems used in diagnosis and therapy. The use of nanoparticles for the development of new nanodrugs requires a deep understanding not only of the properties of nanomaterials, but also of the pathophysiology of diseases. Nanopharmacy help solve complex problems associated with improving the effectiveness of existing therapeutic agents and the use of nanomaterials in the manufacture of nanodrugs.
Reference7 articles.
1. Boisseau P., Loubaton B. Nanoscience and nanotechnologies: hopes and concerns Nanomedicine, nanotechnology in medicine. C. R. Physique. 2011: 620-636
2. EC, Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. ‘A European strategy for Key Enabling Technologies - A bridge to growth and jobs’. Retrieved from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0341:FIN:EN:PDF (2012).
3. Fattal E., Tsapis N. Nanomedicine technology: current achievements and new trends. Clin Transl Imaging (2014) 2:77–87. DOI 10.1007/s40336-014-0053-3
4. Jeevanandam J., Chan Y.S., Danquah M.K. Nano-formulations of drugs: Recent developments, impact and challenges. Biochimie. 2016 Sep-Oct;128-129:99-112. doi: 10.1016/j.biochi.2016.07.008.
5. Hadjidemetriou M., Al-Ahmady Z., Mazza M., Kostarelos K. The Emergence of Nanopharmacy: From Biology to Nanotechnology and Drug Molecules to Nanodrugs (In book: Pharmaceutical Nanotechnology: Innovation and Production). 2016, pp.43-62. DOI: 10.1002/9783527800681.ch3
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献